ALAB250117C110000
- 19.00
- -8.06-29.79%
Astera Labs Newsroom
Stifel Maintains Astera Labs(ALAB.US) With Buy Rating, Raises Target Price to $150
Astera Labs Is Maintained at Buy by Stifel
Astera Labs Analyst Ratings
Astera Labs Price Target Raised to $120.00/Share From $100.00 by Northland Capital Markets
Northland Downgrades Astera Labs to Market Perform From Outperform, Price Target Is $120
Morgan Stanley Maintains Astera Labs(ALAB.US) With Buy Rating, Raises Target Price to $142
Morgan Stanley Reaffirms Their Buy Rating on Astera Labs, Inc. (ALAB)
Astera Labs Analyst Ratings
Morgan Stanley Maintains Overweight on Astera Labs, Raises Price Target to $142
Morgan Stanley Boosts Price Target on Astera Labs to $142 From $94, Keeps Overweight Rating
Barclays Sticks to Its Buy Rating for Astera Labs, Inc. (ALAB)
Roth MKM Maintains Astera Labs(ALAB.US) With Buy Rating, Raises Target Price to $130
Analysts' Top NA Picks: Ibotta, Inc. Class A (IBTA), Astera Labs, Inc. (ALAB)
Analysts Offer Insights on NA Companies: GE Vernova Inc. (GEV) and Astera Labs, Inc. (ALAB)
Astera Labs Analyst Ratings
Citigroup Initiates Coverage On Astera Labs With Buy Rating, Announces Price Target of $120
Stifel Maintains Astera Labs(ALAB.US) With Buy Rating, Maintains Target Price $100
J.P. Morgan Maintains Astera Labs(ALAB.US) With Buy Rating, Raises Target Price to $110
A Quick Look at Today's Ratings for Astera Labs(ALAB.US), With a Forecast Between $100 to $110
Astera Labs Is Maintained at Overweight by Barclays